Burlington, Massachusetts, United States In 1996 was created inVentiv Health, which is appeared as Corporate Investor. The company was established in North America in United States. The main department of described Corporate Investor is located in the Burlington.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the inVentiv Health, startups are often financed by Insight Partners, CHL Medical Partners, MSD Capital. The meaningful sponsors for the fund in investment in the same round are Insight Partners, Exeter Capital Partners, CHL Medical Partners. In the next rounds fund is usually obtained by Insight Partners, Exeter Capital Partners, CHL Medical Partners.
We can highlight the next thriving fund investment areas, such as Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight RxCentric, RxCentric. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2001. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2003.
Related Funds
| Fund Name | Location |
| Changjiang Shaonian Ertong Chubanshe | China, Fujian, Hubei |
| CITIC Startup | Beijing, Beijing, China |
| Direct Group | Doncaster, England, United Kingdom |
| Financial Products Group | Japan, Tokyo |
| Fondo de Fondos | Distrito Federal, Mexico, Mexico City |
| FORWARD.one Venture Capital | Netherlands, Noord-Holland, North Holland |
| Martis Consulting Sp. z o.o. | Mazowieckie, Poland, Warszawa |
| University of Bristol Enterprise Fund | England, London, United Kingdom |
| Zhongjin Huicai | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
RxCentric | $5M | 24 Jul 2001 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
RxCentric | $5M | 24 Jul 2001 | New York, New York, United States |
